Antecedent CHIP in CML?
نویسندگان
چکیده
منابع مشابه
Low-Power Design of CML Drivers for On-Chip Transmission-Lines
In this paper, we discuss a design technique to reduce the power dissipation of CML buffers for on-chip transmissionlines. CML buffers can operate in higher frequency than conventional static CMOS buffers. On the other hand, the power dissipation is larger than that of the static CMOS buffers. We reduce the power dissipation by using an impedance-unmatched driver. From the pole frequency analys...
متن کاملPredicting response in CML.
study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma. Leen AM, et al. Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. Predicting response in chronic myeloid leukemia (CML) patients who are offered tyrosine kinase inhibitor (TKI) second-line therapy is vital...
متن کاملGalen: On antecedent causes
bone chisel. Intriguing in the latter context is the mention of "instrumentists" (organikoi) (e.g. pp. 60ff, 158), whose activities as technicians were sometimes the subject of criticism by medical writers, since, on occasion, their quest to perfect surgical tools seems to have taken precedence over the best interest of the patient. Their inventiveness may, perhaps, be seen, too, in certain par...
متن کاملHow Computer Selects Antecedent?
1. Introduction This study provides a computer-simulated optimal selection of antecedent of reflexive pronouns based on the Visual C++ computer programming language. The algorithm that I use for this implementation is based on the optimal theoretic approach to the proper interpretation of reflexive pronoun roughly adopted in Moon (1999). I show that the complex behavior of reflexive pronouns ca...
متن کاملTargeting kinases in CML CLL.
Among the hematologic malignancies, the genetic lesion in chronic myelogenous leukemia (CML) resulting in Bcr-Abl tyrosine kinase has become a hallmark target for therapeutic intervention. Inhibition of Bcr-Abl tyrosine kinase is a poster child for kinasetargeted therapeutics. Unlike CML, chronic lymphocytic leukemia (CLL) does not have a genetic lesion associated with pathophysiology or biolog...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Blood
سال: 2017
ISSN: 0006-4971,1528-0020
DOI: 10.1182/blood-2016-11-746842